Nuveen
IRON icon

Nuveen’s Disc Medicine IRON Stock Holding History

Nuveen’s Portfolio IRON Stock Details IRON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.41M Buy
60,357
+8,977
+17% +$617K ﹤0.01% 2166
2026
Q1 		$3.29M Buy
51,380
+2,909
+6% +$202K ﹤0.01% 2068
2025
Q4 		$3.85M Buy
48,471
+777
+2% +$65.7K ﹤0.01% 2021
2025
Q3 		$3.15M Sell
47,694
-2,576
-5% -$153K ﹤0.01% 2118
2025
Q2 		$2.66M Sell
50,270
-62,447
-55% -$2.93M ﹤0.01% 2166
2025
Q1 		$5.6M Buy
112,717
+62,596
+125% +$3.48M ﹤0.01% 1866
2024
Q4 		$3.18M Sell
50,121
-44,683
-47% -$2.58M ﹤0.01% 2189
2024
Q3 		$4.66M Buy
94,804
+38,883
+70% +$1.83M ﹤0.01% 2022
2024
Q2 		$2.52M Buy
55,921
+16,316
+41% +$554K ﹤0.01% 2272
2024
Q1 		$2.47M Buy
39,605
+5,673
+17% +$368K ﹤0.01% 2301
2023
Q4 		$1.96M Buy
33,932
+13,867
+69% +$710K ﹤0.01% 2417
2023
Q3 		$943K Sell
20,065
-14,940
-43% -$747K ﹤0.01% 2598
2023
Q2 		$1.55M Buy
+35,005
New +$1.24M ﹤0.01% 2465
2022
Q2 		– Sell
-2,689
Closed -$116K – 3372
2022
Q1 		$116K Buy
2,689
+115
+4% +$6.03K ﹤0.01% 3241
2021
Q4 		$228K Sell
2,574
-250
-9% -$24.5K ﹤0.01% 3221
2021
Q3 		$404K Buy
2,824
+745
+36% +$102K ﹤0.01% 3205
2021
Q2 		$403K Buy
+2,079
New +$684K ﹤0.01% 3188

Other funds holding IRON

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Nuveen's IRON Position: Q2 2026 in Review

Nuveen increased its Disc Medicine (IRON) stake by 17% in Q2 2026, buying an estimated $617K and bringing the position to 60,357 shares worth $4.41M. The position accounts for ﹤0.01% of the portfolio, ranked #2166.

Nuveen first reported a position in IRON in Q2 2021 and has held it in 17 quarters since. The position peaked at $5.6M in Q1 2025. 216 funds tracked by Wall St. Rank hold IRON as of Q2 2026.

  • Nuveen held 60,357 shares of Disc Medicine worth $4.41M as of Q2 2026.
  • Nuveen bought 8,977 Disc Medicine shares in Q2 2026, an estimated $617K.
  • Disc Medicine made up ﹤0.01% of Nuveen's portfolio in Q2 2026, its #2166 holding.
  • Nuveen first reported a position in Disc Medicine in Q2 2021 and has held it in 17 quarters since.
  • Nuveen's Disc Medicine position peaked at $5.6M in Q1 2025.
  • 216 funds tracked by Wall St. Rank held Disc Medicine as of Q2 2026.

Based on Nuveen's 13F filing for Q2 2026, filed 11 Aug 2026.